Vivek Juneja Upgraded (WFC) to Buy and Increased Target to $60 on, Oct 9th, 2015

Show Health and Fitness Publications

Mon, November 14, 2016

[ Mon, Nov 14th 2016 ]: Market Wire

New Analyses of Phase 3 Trials Show Improvements .. oms Following Treatment with Baricitinib Across D

[ Mon, Nov 14th 2016 ]: Market Wire

Baricitinib Demonstrates Early Response Compared .. provement Compared to Adalimumab in Patient-Repor

Sun, November 13, 2016

[ Sun, Nov 13th 2016 ]: Market Wire

Jardiance (empagliflozin) consistently reduced th .. h in adults with type 2 diabetes regardless of th

Wed, November 9, 2016

[ Wed, Nov 09th 2016 ]: Market Wire

COLUMBUS Phase 3 Study Results in BRAF-Mutant Mel .. at Society for Melanoma Research Annual Congress

Thu, November 3, 2016

[ Thu, Nov 03rd 2016 ]: Market Wire

Lilly Presents Clinical Efficacy, Safety and Pati .. Baricitinib in Patients with Rheumatoid Arthriti

Wed, November 2, 2016

[ Wed, Nov 02nd 2016 ]: Market Wire

New data from pivotal RA-BEACON study show signif .. reported outcomes in rheumatoid arthritis patient

Mon, October 17, 2016

[ Mon, Oct 17th 2016 ]: Market Wire

Lilly Partners with the National Cancer Institute .. h through New Program under Cancer Moonshot Initi

Sat, October 8, 2016

[ Sat, Oct 08th 2016 ]: Market Wire

New Data on the Combination of Lilly's ALIMTA (pe .. A (pembrolizumab) Show a Near-Doubling of Objecti

Thu, October 6, 2016

[ Thu, Oct 06th 2016 ]: Market Wire

Research Reports Initiation on Healthcare Stocks -- NuVasive, Nevro, Spectranetics, and NovoCure

[ Thu, Oct 06th 2016 ]: Market Wire

Technical Roundup on Drug Makers Stocks -- Tonix .. rma, Retrophin, Heron Therapeutics, and GW Pharma

Wed, October 5, 2016

[ Wed, Oct 05th 2016 ]: Market Wire

Research Reports Coverage on Generic Drugs Stocks .. ernus Pharma, Lipocine, and Carbylan Therapeutics

[ Wed, Oct 05th 2016 ]: Market Wire

Biotech Stocks Technical Reports -- Peregrine Pha .. rapeutics, Aratana Therapeutics, and Vanda Pharma

[ Wed, Oct 05th 2016 ]: Market Wire

Lilly Highlights Advancements in its Oncology Portfolio with New Data at ESMO 2016

Mon, October 3, 2016

[ Mon, Oct 03rd 2016 ]: Market Wire

Biotechs with Key Corporate Developments

Fri, September 30, 2016

[ Fri, Sep 30th 2016 ]: Market Wire

Biotechs and the Advancements in Cancer Oriented Clinical Trials

[ Fri, Sep 30th 2016 ]: Market Wire

The Medical Device Industry's Focus on Cardio and Cardiovascular Needs

Thu, September 29, 2016

[ Thu, Sep 29th 2016 ]: Market Wire

Awareness Continues to Grow for Medical Uses of Cannabis

Tue, September 27, 2016

[ Tue, Sep 27th 2016 ]: Market Wire

Fighting Addiction and Other Unmet Medical Needs with Cannabidiol

[ Tue, Sep 27th 2016 ]: Market Wire

Multi-Billion Dollar Cannabis Operations Boosting .. ewest Cultivation Uses of Liquid Fulvic and Humic

[ Tue, Sep 27th 2016 ]: Market Wire

ProNAi Licenses Oncology Drug Targeting DNA Damag .. ckpoint Kinase 1 (Chk1) From CRT Pioneer Fund, UK

Mon, September 26, 2016

[ Mon, Sep 26th 2016 ]: Market Wire

The Week Many Have Been Waiting For

[ Mon, Sep 26th 2016 ]: Market Wire

The Bioscience and Biotechnology Sector Developments in Cancer Therapy

Fri, September 23, 2016

[ Fri, Sep 23rd 2016 ]: Market Wire

Shire to Showcase Continued Innovation and Leader .. uring European Society for Immunodeficiencies Bie

Thu, September 22, 2016

[ Thu, Sep 22nd 2016 ]: Market Wire

Biotechnology Companies Reaching New Milestones

[ Thu, Sep 22nd 2016 ]: Market Wire

Research Reports Coverage on Select Healthcare St .. obus Medical, Align Technology, and Nxstage Medic

[ Thu, Sep 22nd 2016 ]: Market Wire

Biotech Stocks on Investors' Radar -- Portola Pha .. bluebird bio, Auris Medical, and Cerulean Pharma

Wed, September 21, 2016

[ Wed, Sep 21st 2016 ]: Market Wire

Research Reports Coverage on Healthcare Stocks -- Aetna, Anthem, Humana, and BioScrip

Tue, September 20, 2016

[ Tue, Sep 20th 2016 ]: Market Wire

Advancing Preclinical Autoimmune Studies & Accele .. FDA Approvals Producing Rewards in Biotech Sector

[ Tue, Sep 20th 2016 ]: Market Wire

Generic Drugs Stocks on Investors' Radar -- Zoeti .. ris Bio, Rigel Pharma, and Neurocrine Biosciences

[ Tue, Sep 20th 2016 ]: Market Wire

Research Reports Initiation on Biotech Stocks -- .. ktar Therapeutics, GlobeImmune and Anthera Pharma

Mon, September 19, 2016

[ Mon, Sep 19th 2016 ]: Market Wire

Research Reports Initiation on Biotech Stocks -- .. apeutix, Infinity Pharma, Lpath, and Idera Pharma

[ Mon, Sep 19th 2016 ]: Market Wire

Research Reports Initiation on Specialized Health .. hcare Services, Healthways, MEDNAX, and HEALTHSOU

Sun, September 18, 2016

[ Sun, Sep 18th 2016 ]: Market Wire

Health Care Stocks on Investors' Radar -- Centene .. gna, Molina Healthcare, and WellCare Health Plans

Fri, September 16, 2016

[ Fri, Sep 16th 2016 ]: Market Wire

Technical Roundup on Healthcare Stocks -- ResMed, MiMedx, Varian Medical Systems, and Accuray

[ Fri, Sep 16th 2016 ]: Market Wire

Research Reports on Biotech Equities -- Galena Biopharma, Mast Therapeutics, Medivation, and Amgen

[ Fri, Sep 16th 2016 ]: Market Wire

CHMP Recommends Approval of Lilly's Olaratumab, i .. ith Doxorubicin, for Advanced Soft Tissue Sarcoma

Thu, September 15, 2016

[ Thu, Sep 15th 2016 ]: Market Wire

Boston Mayor Walsh and the Alzheimer's Associatio .. hire Chapter, Receive Alzheimer's Readiness Award

[ Thu, Sep 15th 2016 ]: Market Wire

Drug Makers Stocks Technical Reports -- Pernix Th .. rgy Pharma, Novo Nordisk, and Apricus Biosciences

Wed, September 14, 2016

[ Wed, Sep 14th 2016 ]: Market Wire

Research Reports Initiation on Healthcare Stocks .. , AmSurg, Quintiles Transnational, and Acadia Hea

[ Wed, Sep 14th 2016 ]: Market Wire

Shire Announces U.S. FDA Approval of CUVITRU[TM] .. (Human), 20% Solution] Treatment for Primary Imm

Mon, September 12, 2016

[ Mon, Sep 12th 2016 ]: Market Wire

Healthcare Stocks Technical Reports -- EnteroMedics, Neovasc, Amedica, and InspireMD

Fri, September 9, 2016

[ Fri, Sep 09th 2016 ]: Market Wire

Research Reports Coverage on Healthcare Stocks -- .. rma, Sanofi, Shire, and Universal Health Services

Thu, May 9, 2013

[ Thu, May 09th 2013 ]: Market Wire

Sunshine Heart, Inc. Announces First Patient Impl .. nted in C-Pulse System European Post-Market Study

[ Thu, May 09th 2013 ]: Market Wire

Trevena, Inc. and Forest Laboratories Announce a .. evelopment of TRV027 for the Treatment of Acute H

Wed, May 8, 2013

[ Wed, May 08th 2013 ]: Market Wire

Vorteile der Mammografie-Technologie zur Brust-To .. ner verffentlichten italienischen Studie besttigt

[ Wed, May 08th 2013 ]: Market Wire

I benefici della tecnologia Hologic per l'utilizz .. o corroborati dalla pubblicazione di uno studio i

Tue, May 7, 2013

[ Tue, May 07th 2013 ]: Market Wire

Luminex Corporation To Present At Upcoming Investment Conferences

[ Tue, May 07th 2013 ]: Market Wire

Gatorz Inc. Issues Stock Options and Mails Meeting Materials

Vivek Juneja Upgraded (WFC) to Buy and Increased Target to $60 on, Oct 9th, 2015

//stocks-investing.news-articles.net/content/201 .. -and-increased-target-to-60-on-oct-9th-2015.html

Published in Stocks and Investing on Friday, October 25th 2024 at 10:12 GMT by WOPRAI
^{🞛 This publication is a summary or evaluation of another publication}

Vivek Juneja of JP Morgan, Upgraded "Wells Fargo & Company" (WFC) to Buy and Increased Target from $59 to $60 on, Oct 9th, 2015.

Vivek has made no other calls on WFC in the last 4 months.

There are 4 other peers that have a rating on WFC. Out of the 4 peers that are also analyzing WFC, 1 agrees with Vivek's Rating of Hold. Following is the relevant analyst calls for the last 4 months

Brian Kleinhanzl of "Keefe, Bruyette & Woods" Maintained at Hold with Increased Target to $61 on, Wednesday, July 15th, 2015

These are the ratings of the 3 analyists that currently disagree with Vivek

David Konrad of "Macquarie" Maintained at Sell with Decreased Target to $50 on, Friday, September 25th, 2015
John Pancari of "Evercore ISI Group" Upgraded from Hold to Strong Buy on, Tuesday, September 8th, 2015
Eric Wasserstrom of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, July 29th, 2015

Similar Health and Fitness Publications

[ Fri, Sep 25th 2015 ]: WOPRAI
Category: Stocks and Investing

David Konrad Maintained (WFC) at Sell with Decreased Target to $50 on, Sep 25th, 2015

[ Tue, Sep 08th 2015 ]: WOPRAI
Category: Stocks and Investing

John Pancari Upgraded (WFC) to Strong Buy on, Sep 8th, 2015

[ Wed, Jul 29th 2015 ]: WOPRAI
Category: Stocks and Investing

Eric Wasserstrom Upgraded (WFC) to Strong Buy on, Jul 29th, 2015

[ Wed, Jul 15th 2015 ]: WOPRAI
Category: Stocks and Investing

Brian Kleinhanzl Maintained (WFC) at Hold with Increased Target to $61 on, Jul 15th, 2015

[ Mon, May 11th 2015 ]: WOPRAI
Category: Stocks and Investing

Jack Micenko Maintained (WFC) at Hold with Decreased Target to $58 on, May 11th, 2015

[ Fri, Apr 17th 2015 ]: WOPRAI
Category: Stocks and Investing

Brian Kleinhanzl Maintained (C) at Buy with Increased Target to $63 on, Apr 17th, 2015

[ Wed, Apr 15th 2015 ]: WOPRAI
Category: Stocks and Investing

David Konrad Maintained (WFC) at Sell with Increased Target to $51 on, Apr 15th, 2015

[ Fri, Jan 16th 2015 ]: WOPRAI
Category: Stocks and Investing

Keith Horowitz Maintained (WFC) at Hold with Increased Target to $55 on, Jan 16th, 2015

[ Tue, Jan 13th 2015 ]: WOPRAI
Category: Stocks and Investing

John Pancari Initiated (WFC) at Hold and Held Target at $57 on, Jan 13th, 2015

[ Fri, Oct 17th 2014 ]: WOPRAI
Category: Stocks and Investing

Keith Horowitz Maintained (WFC) at Hold with Decreased Target to $54 on, Oct 17th, 2014

[ Thu, Oct 16th 2014 ]: WOPRAI
Category: Stocks and Investing

Stephen Biggar Upgraded (WFC) to Strong Buy and Held Target at $54 on, Oct 16th, 2014

[ Tue, Oct 08th 2013 ]: WOPRAI
Category: Stocks and Investing

David Konrad Downgraded (WFC) to Hold on, Oct 8th, 2013